Respiratory Infections News

WHO this week announced a project to speed development of a messenger RNA vaccine against highly pathogenic avian influenza in humans.

CMS included a new infectious disease consult add-on code as part of its proposed new fee schedule could help improve compensation for ID clinicians, according to the Infectious Diseases Society of America.

The Pan American Health Organization issued an epidemiological alert in July regarding a significant rise in pertussis cases in the Americas and across the globe, according to a press release.

Influenza is responsible for significant mortality and hospitalization rates in the United States, ranging from 4,900 to 51,000 deaths and 100,000 to 710,000 hospitalizations annually between 2010 and 2023, according to the CDC.

ID is a dynamic field that is constantly changing. The types of infections we’re talking about today are different than what we may have been talking about 5 years ago. So, it’s intellectually stimulating and challenging.

Infections are the primary cause of nonrelapse mortality among individuals who undergo chimeric antigen receptor T-cell therapy, according to study results.

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

The CDC said it has confirmed four new cases of highly pathogenic avian influenza in Colorado poultry workers and is aware of a fifth presumptive-positive case.

The severity of a SARS-CoV-2 reinfection is likely to be similar to the severity of a patient’s initial infection, researchers found.

A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.